Pollens from grass, weeds, and trees
Mold spores and mold fragments
Animal danders (hair, skin and feathers) and saliva
Dust mite feces
Cockroach feces
Food allergens: food preservatives like potassium bisulphate and sodium benzoate.
Other food allergens are egg, milk, peanut, sesame and others.
Smokes from fire place, candles, fireworks, and incense sticks.
Tobacco smoke
Air pollution
Cold air
Strong chemical odors and perfumes
Dusty work places
Following exposure to allergens, allergic reaction sets up in airways.
There is a complex interaction btw mast cells, IgE, esinophils, T- lymphocytes, macrophages and dendritic cells.
These cells release many mediators like Leukotriene C4, interferons and cytokines.
These mediators cause constriction and spasm of bronchial airways, edema of bronchial walls and mucus plugging the airways.
Long term changes in airways referred to as airway modeling, can lead to fibrosis and irreversible airway obstruction in some of the patients.CC
Cough with expectoration
Wheezing
Shortness of breathe
Chest pain and tightening
Rapid breathing
|
Intermittent |
Mild persistent |
Moderate persistent |
Severe persistent |
Day time symptoms |
Daytime symptoms 2 or fewer times/week |
Daytime symptoms >2 per week. but not daily |
Daily symptoms |
Symptoms through the day |
Night time awakening |
Night time awakenings 2 or fewer times/month |
Night time awakenings 3-4 times per month |
More than 1/week |
7 times/week |
Use of beta agonist |
2 or fewer times/month |
>2 times per month, but not daily |
Daily use |
Several times per day |
Interference in normal activity |
None |
Minor limitation |
Some limitation |
Extremely limited |
Lung function tests |
FEV1 >80% FEV1/FVC ratio normal |
FEV1 >80% FEV1/FVC ratio normal |
FEV1 >60% but <80% predicted, FEV1/FVC ratio reduced 5% |
FEV1 <60% predicted, FEV1/FVC ratio reduced more than 5% |
Exacerbations requiring of systemic corticosteroids |
One per year at most |
2 or more exacerbations per year |
2 or more exacerbation per year |
2 or more exacerbations per year |
Recommended therapy |
Step 1- Short acting beta agonists |
Step 2- Low dose steroid inhalers, or Cromolyn, Leukotriene inhibitors, Theophylline |
Step 3- Low dose oral corticosteroids + low-dose inhaled corticosteroids + long-acting beta-agonist |
Step 4- Low dose oral corticosteroids + low-dose inhaled corticosteroids + long-acting beta-agonist+ Leukotriene receptor antagonist, Theophylline, or zileuton. To consider anti-IgE therapy Omalizumab in allergic patients. |
To consider allergic immunotherapy in allergic patients
Serum IgE levels
Absolute esinophils
Sputum examination
Chest radiography
Chest CT scan
Echocardiogram
Pulmonary function test
Corticosteroids
Inhaled steroids: Budesenoid, Fluticasone, Flunisolide, Betamethasone)
Systemic steroids: Prednisolone, Hydrocortisone, and Methyl prednisolone.
Bronchodilators
Short acting beta agonists: Salbutamol, Albuterol
Long acting beta agonists: Salmetrol, Formoterol
Methyl Xanthine: Theophylline, Deriphylline
Anticholinergics: Ipratropium and Tiotropium bromide
Leukotriene-modifying agents
Zakirlukast, Motelukast, and Zileuton
Mast cell stabilizing agents
Sodium chromoglycate, Nedocromil and Ketotinfen
Omalizumab
DNA derived human IgG monoclonal antibody that binds selectively to human IgE receptor on surface of mast cells and basophils.
It down regulates the mediators of allergic response in asthma.
Indicated in moderate to severe persistent asthma.
Allergen avoidance- A multifaceted approach is necessary, as individual interventions are rarely successful.
Allergen immunotherapy should be considered in those the specific allergens have a proven relationship to symptoms.